Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life

被引:8
作者
Allegaert, K.
Verbesselt, R.
Rayyan, M.
Debeer, A.
de Hoon, J.
机构
[1] Univ Hosp Gasthuisberg, Div Woman & Child, Neonatal Intens Care Unit, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Ctr Clin Pharmacol, B-3000 Louvain, Belgium
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2007年 / 29卷 / 04期
关键词
cytochrome P450; developmental pharmacology; drug metabolism; maturation; ontogeny; UDP; glucurosyltransferase;
D O I
10.1358/mf.2007.29.4.1106408
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to size-dependent allometric metabolic activity, most isoenzymes display age-dependent isoenzyme-specific outogeny. We therefore need probe drugs to describe isoenzyme-specific outogeny to develop more sophisticated, physiologically based models. we illustrate the feasibility and the relevance of in vivo assesment of hepatic metabolism, based on observations on urinary elimination of paracetamol and tramadol metabolites in neonates. On the basis of the observations on tramadol disposition, we were able to document that O-demethylation phenotypic activity developed soooner when compared with N-demethylation. During repeated administration of intravenous paracetamol, it was documented that in addition to postmenstrual and postnatal age (PNA), repeated administration also contributed to the urinary excretion of glucuronidated paracetamol. In both prob drugs evaluated, age only in part explained the interindividual variability observed. Urine metabolites to assess in vivo metabolism of drugs routinely administered in neonates likely increase both the feasibility and clinical relevance of studies on in vivo isoenzyme-specific ontogeny in neonates. (C) 2007 Prous Science. All rights reserved.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 37 条
[1]   Concordance between tramadol and dextromethorphan parent/metabolite ratios: The influence of CYP2D6 and non-CYP2D6 pathways on biotransformation [J].
Abdel-Rahman, SM ;
Leeder, JS ;
Wilson, JT ;
Gaedigk, A ;
Gotschall, RR ;
Medve, R ;
Liao, S ;
Spielberg, SP ;
Kearns, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (01) :24-29
[2]   Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity [J].
Aleksa, K ;
Matsell, D ;
Krausz, K ;
Gelboin, H ;
Ito, S ;
Koren, G .
PEDIATRIC NEPHROLOGY, 2005, 20 (07) :872-885
[3]   Contribution of glucuronidation to tramadol disposition in early neonatal life [J].
Allegaert, K ;
Rayyan, M ;
de Hoon, J ;
Tibboel, D ;
Verbesselt, R ;
Naulaers, G ;
Van den Anker, JN ;
Devlieger, H .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (01) :110-112
[4]  
Allegaert K, 2006, INT J CLIN PHARM TH, V44, P303
[5]   Comments on "shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats" [J].
Allegaert, K ;
Tibboel, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02) :966-967
[6]   O-demethylation of tramadol in the first months of life [J].
Allegaert, K ;
Van den Anker, JN ;
Verbesselt, R ;
de Hoon, J ;
Vanhole, C ;
Tibboel, D ;
Devlieger, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (11) :837-842
[7]   Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates [J].
Allegaert, K ;
De Hoon, J ;
Verbesselt, R ;
Vanhole, C ;
Devlieger, H ;
Tibboel, D .
ACTA PAEDIATRICA, 2005, 94 (09) :1273-1279
[8]   Tramadol disposition in the very young:: an attempt to assess in vivo cytochrome P-450 2D6 activity [J].
Allegaert, K ;
Anderson, BJ ;
Verbesselt, R ;
Debeer, A ;
de Hoon, J ;
Devlieger, H ;
Van den Anker, JN ;
Tibboel, D .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (02) :231-239
[9]   Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates [J].
Allegaert, K ;
Anderson, BJ ;
Naulaers, G ;
de Hoon, J ;
Verbesselt, R ;
Debeer, A ;
Devlieger, H ;
Tibboel, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (03) :191-197
[10]   Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis [J].
Anderson, BJ ;
Pons, G ;
Autret-Leca, E ;
Allegaert, K ;
Boccard, E .
PEDIATRIC ANESTHESIA, 2005, 15 (04) :282-292